Universal Biosensors, Inc. (UBI.AX)
AUD 0.05
(-1.89%)
AUD 0.05
(-1.89%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -16.68 Million AUD | 12.57% |
| 2022 | -19.07 Million AUD | -73.64% |
| 2021 | -10.98 Million AUD | -12.9% |
| 2020 | -9.73 Million AUD | 6.42% |
| 2019 | -10.39 Million AUD | -122.4% |
| 2018 | 46.42 Million AUD | 4469.1% |
| 2017 | 1.01 Million AUD | 127.29% |
| 2016 | -3.72 Million AUD | 64.19% |
| 2015 | -10.39 Million AUD | 24.58% |
| 2014 | -13.78 Million AUD | 24.41% |
| 2013 | -18.23 Million AUD | -96.47% |
| 2012 | -9.28 Million AUD | 39.75% |
| 2011 | -15.4 Million AUD | -97.42% |
| 2010 | -7.8 Million AUD | -1337.38% |
| 2009 | 630.64 Thousand AUD | 104.34% |
| 2008 | -14.52 Million AUD | -60.09% |
| 2007 | -9.07 Million AUD | -190.53% |
| 2006 | -3.12 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.65 Million AUD | 7.68% |
| 2024 Q2 | -4.51 Million AUD | -23.42% |
| 2024 Q3 | -4.03 Million AUD | 10.62% |
| 2023 FY | -16.68 Million AUD | 12.57% |
| 2023 Q2 | -4.44 Million AUD | -12.04% |
| 2023 Q1 | -3.96 Million AUD | 16.39% |
| 2023 Q3 | -3.75 Million AUD | 15.49% |
| 2023 Q4 | -3.95 Million AUD | -5.35% |
| 2022 Q3 | -5.12 Million AUD | -8.9% |
| 2022 Q4 | -4.74 Million AUD | 7.43% |
| 2022 FY | -19.07 Million AUD | -73.64% |
| 2022 Q1 | -4.49 Million AUD | 24.37% |
| 2022 Q2 | -4.7 Million AUD | -4.74% |
| 2021 Q1 | -2.41 Million AUD | 3.49% |
| 2021 Q3 | -4.02 Million AUD | -51.82% |
| 2021 Q4 | -5.94 Million AUD | -47.63% |
| 2021 Q2 | -2.65 Million AUD | -9.74% |
| 2021 FY | -10.98 Million AUD | -12.9% |
| 2020 Q2 | -3.82 Million AUD | -15.74% |
| 2020 Q3 | -2.92 Million AUD | 23.35% |
| 2020 FY | -9.73 Million AUD | 6.42% |
| 2020 Q1 | -3.3 Million AUD | -33.25% |
| 2020 Q4 | -2.5 Million AUD | 14.54% |
| 2019 Q3 | -2.37 Million AUD | -5.96% |
| 2019 FY | -10.39 Million AUD | -122.4% |
| 2019 Q4 | -2.47 Million AUD | -4.16% |
| 2019 Q2 | -2.24 Million AUD | 31.88% |
| 2019 Q1 | -3.29 Million AUD | -189.52% |
| 2018 FY | 46.42 Million AUD | 4469.1% |
| 2018 Q4 | 3.68 Million AUD | -91.28% |
| 2018 Q3 | 42.25 Million AUD | 18781.61% |
| 2018 Q2 | -226.16 Thousand AUD | -131.63% |
| 2018 Q1 | 715.11 Thousand AUD | 147.59% |
| 2017 Q4 | -1.5 Million AUD | -163.23% |
| 2017 FY | 1.01 Million AUD | 127.29% |
| 2017 Q1 | 2.52 Million AUD | 271.48% |
| 2017 Q2 | 567.12 Thousand AUD | -77.52% |
| 2017 Q3 | -570.83 Thousand AUD | -200.65% |
| 2016 Q1 | -1.58 Million AUD | 15.53% |
| 2016 FY | -3.72 Million AUD | 64.19% |
| 2016 Q3 | -2.1 Million AUD | -246.71% |
| 2016 Q2 | 1.43 Million AUD | 190.39% |
| 2016 Q4 | -1.47 Million AUD | 29.96% |
| 2015 Q2 | -2.55 Million AUD | 27.65% |
| 2015 Q4 | -1.87 Million AUD | -82.64% |
| 2015 Q3 | -1.02 Million AUD | 59.86% |
| 2015 Q1 | -3.53 Million AUD | -75.48% |
| 2015 FY | -10.39 Million AUD | 24.58% |
| 2014 Q1 | -4.96 Million AUD | -10.36% |
| 2014 FY | -13.78 Million AUD | 24.41% |
| 2014 Q4 | -2.01 Million AUD | 55.21% |
| 2014 Q3 | -4.49 Million AUD | -1.13% |
| 2014 Q2 | -4.44 Million AUD | 10.41% |
| 2013 Q2 | -3.92 Million AUD | 17.3% |
| 2013 Q1 | -4.74 Million AUD | -3.98% |
| 2013 FY | -18.23 Million AUD | -96.47% |
| 2013 Q4 | -4.49 Million AUD | 11.23% |
| 2013 Q3 | -5.06 Million AUD | -29.02% |
| 2012 Q3 | -1.23 Million AUD | -19.32% |
| 2012 FY | -9.28 Million AUD | 39.75% |
| 2012 Q2 | -1.03 Million AUD | 57.55% |
| 2012 Q1 | -2.44 Million AUD | 0.0% |
| 2012 Q4 | -4.56 Million AUD | -269.08% |
| 2011 Q1 | -3.14 Million AUD | 0.0% |
| 2011 FY | -15.4 Million AUD | -97.42% |
| 2011 Q3 | -4.24 Million AUD | 12.6% |
| 2011 Q2 | -4.86 Million AUD | -54.71% |
| 2010 Q1 | -1.39 Million AUD | 0.0% |
| 2010 Q3 | -1.74 Million AUD | 42.04% |
| 2010 Q2 | -3 Million AUD | -116.42% |
| 2010 FY | -7.8 Million AUD | -1337.38% |
| 2009 Q3 | -4.17 Million AUD | 14.52% |
| 2009 FY | 630.64 Thousand AUD | 104.34% |
| 2009 Q2 | -4.88 Million AUD | -89.08% |
| 2009 Q1 | -2.58 Million AUD | 0.0% |
| 2008 FY | -14.52 Million AUD | -60.09% |
| 2007 FY | -9.07 Million AUD | -190.53% |
| 2006 FY | -3.12 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 40.356% |
| Adherium Limited | -11.98 Million AUD | -39.173% |
| Aroa Biosurgery Limited | -9.78 Million AUD | -70.421% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -282.447% |
| Anteris Technologies Ltd | -66.63 Million AUD | 74.967% |
| Control Bionics Limited | -5.92 Million AUD | -181.322% |
| CardieX Limited | -4.63 Million AUD | -259.977% |
| Compumedics Limited | -269 Thousand AUD | -6100.863% |
| Cochlear Limited | 521.5 Million AUD | 103.199% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -246.499% |
| Cyclopharm Limited | -9.22 Million AUD | -80.823% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -933.215% |
| Nova Eye Medical Limited | -3.79 Million AUD | -339.303% |
| HeraMED Limited | -6.42 Million AUD | -159.495% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 5.093% |
| ImpediMed Limited | -19.03 Million AUD | 12.375% |
| InhaleRx Limited | -1.38 Million AUD | -1103.064% |
| LBT Innovations Limited | -4.74 Million AUD | -251.906% |
| Micro-X Limited | -13.02 Million AUD | -28.044% |
| Neurotech International Limited | -5.58 Million AUD | -198.674% |
| OncoSil Medical Limited | -11.98 Million AUD | -39.186% |
| PolyNovo Limited | 1.16 Million AUD | 1534.249% |
| Respiri Limited | -7 Million AUD | -138.283% |
| SomnoMed Limited | -3.84 Million AUD | -334.237% |
| Uscom Limited | -2.4 Million AUD | -593.756% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -184.933% |